Efficacy of Two Types of Non-invasive Erector Spinae Muscle Taut Band Therapy in University Students With Low Back Pain

NCT05279794 | Completed

• 1 other identifier: CE012207
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

Non-specific low back pain can be caused by the presence of active trigger points in the muscles of the lumbopelvic region. Trigger points are defined as hypersensitive points within a taut band of a musculoskeletal system that cause pain during contraction, stretching, or stimulation of said muscle. If these points are active, they can trigger referred pain, local tenderness, and vegetative responses. There is scientific evidence of the improvement of the treatment of these points through non-invasive manual techniques. The objective of this study will be to determine the effect of Strain Counterstrain and Myofascial Induction techniques in subjects with low back pain secondary to the presence of active trigger points in the lumbopelvic region. Hyperexcitable myofascial trigger points located within a taut band of skeletal muscle or fascia cause referred pain, local tenderness, and autonomic changes. The scientific data refer to an immediate improvement in the symptoms of these active points treated with manual therapy. Based on these factors, the objective of the study is to determine the effect of the combined therapy of the Strain Counterstrain technique and Myofascial Induction in participants with the presence of an active trigger point in the erector spinae muscle.

Conditions

Low Back Pain; Trigger Point Pain, Myofascial

Keywords

Physiotherapy; Rehabilitation; Treatment; Active Trigger Point

Outcome Measures

Primary Outcomes (2)

• Pain intensity

  Measured with Numeric Rating Scale wich consist in measure pain intensity with a score of 0-10

  20 minutes

• Pression algometer

  Measures pressure pain thresholds

  20 minutes

Secondary Outcomes (2)

• Spinal test

  20 minutes

• Countermovement jump test

  20 minutes

Study Arms (3)

Jones Group (Strain Counterstrain)

EXPERIMENTAL

Jones Group consist in 90 seconds in a ralease positioning of no pain in muscle acortation

Other: Jones Group (Strain Counterstrain)

Myofascial Induction Group

ACTIVE COMPARATOR

Myofascial Induction Group consist in 15 minutes of superficial and deep lumbar fascia maneuvers

Other: Myofascial Induction Group

Placebo Group

PLACEBO COMPARATOR

Placebo Group only have to mantain no pain positioning for 3 minutes

Other: Placebo Group

Interventions

Jones Group (Strain Counterstrain) OTHER

No pain positioning technique with diaphragmatic breathing

Jones Group (Strain Counterstrain)

Myofascial Induction Group OTHER

Myofascial Induction technique on the lumbar fascia

Myofascial Induction Group

Placebo Group OTHER

No pain positioning of participants

Placebo Group

Eligibility Criteria

• Age: 19 Years - 40 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Presence of low back pain
• Presence of active trigger point in the erector spinae as described by Lawrence H. Jones

You may not qualify if:

• Participants who present dizziness, vertigo;
• Previous or scheduled surgeries in the lumbar spine and/or lower extremities;
• Suspicion of serious fractures or pathologies (tumor, inflammation, infection, rheumatological disorder, systemic disease, presence of fever);
• Diagnosis of radiculopathy or neuropathy;
• Structural deformity in the spine; spondyloarthropathy, disabling pain and physical disability;
• Use of pain relievers or anti-inflammatory drugs in the last 48 hours;
• Neurological or psychiatric disorder;
• Presence or suspicion of pregnancy

Sponsors & Collaborators

• Universidad Católica San Antonio de Murcia: lead

Study Sites (1)

Universidad Católica de Murcia

Murcia, 30107, Spain

Location

MeSH Terms

Conditions

Low Back Pain; Myofascial Pain Syndromes

Condition Hierarchy (Ancestors)

Back Pain; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Muscular Diseases; Musculoskeletal Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: CARE PROVIDER, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Study Director

Study Record Dates

• First Submitted: February 7, 2022
• First Posted: March 15, 2022
• Study Start: March 21, 2022
• Primary Completion: March 23, 2022
• Study Completion: May 19, 2022
• Last Updated: May 20, 2022

Record last verified: 2022-05

Locations

ES (1)